Corient Private Wealth
ACH

Corient Private Wealth’s Accendra Health ACH Stock Holding History

Corient Private Wealth’s Portfolio ACH Stock Details ACH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$40.2K Buy
+11,750
New +$36.5K ﹤0.01% 3005

Other funds holding ACH

CCM
Coliseum Capital Management Rowayton, Connecticut $1.16B AUM 23.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Corient Private Wealth's ACH Position: Q2 2026 in Review

Corient Private Wealth opened a new position in Accendra Health (ACH) in Q2 2026: 11,750 shares worth $40.2K. The stake represents ﹤0.01% of the portfolio and ranks #3005 among its holdings.

139 funds tracked by Wall St. Rank hold ACH as of Q2 2026.

  • Corient Private Wealth held 11,750 shares of Accendra Health worth $40.2K as of Q2 2026.
  • Accendra Health was a new Corient Private Wealth position in Q2 2026.
  • Accendra Health made up ﹤0.01% of Corient Private Wealth's portfolio in Q2 2026, its #3005 holding.
  • 139 funds tracked by Wall St. Rank held Accendra Health as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.